NCT04503265 2025-05-01A Trial of AMXI-5001 for Treatment in Patients With Advanced MalignanciesAtlasMedx, IncorporatedPhase 1/2 Recruiting122 enrolled
NCT03804866 2019-01-15NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)AGC Biologics S.p.A.Phase 2 Completed14 enrolled